NEW YORK (GenomeWeb News) – PharmiGene said today that the Department of Health in Taiwan has granted the firm approval to market its PG 1502 DNA detection kit on the island.
 
The test is used to identify patients at greater risk for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis, which are life-threatening adverse drug reactions. Carbamazepine is an anti-convulsant and mood-stabilizing drug used to treat epilepsy, biopolar disorder, and schizophrenia, among other conditions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.